Advertisement

Cognitive impairment in multiple sclerosis: An 18 year follow-up study

      Highlights

      • The present study is one of the longest longitudinal studies of cognition in multiple sclerosis (MS).
      • This is a unique sample consisting of individuals from the original Avonex study conducted in the early 1990s.
      • Findings demonstrate the natural evolution of cognitive changes over time in MS.

      Abstract

      Background

      Cognitive impairment occurs in 40–65% of patients with multiple sclerosis (MS). Less is known about the rate and pattern of cognitive decline over the course of the illness.

      Objective

      To examine long-term changes in cognition among patients enrolled in the phase III clinical trial of intramuscular interferon beta-1a (IM IFNβ-1a).

      Methods

      Twenty-two patients underwent a longitudinal investigation comparing neuropsychological test performance at study entry and 18-year follow-up.

      Results

      Over the 18 year interval, significant declines were observed on measures of information processing speed, simple and complex auditory attention, episodic learning and memory, and visual construction. Nine patients (41%) were found to be cognitively impaired at study entry. At follow-up 13 patients (59%) were cognitively impaired. While both the impaired and unimpaired patients at baseline experienced declines on these measures, only one measure, the Symbol Digit Modalities Test (SDMT), demonstrated a group (cognitively impaired versus intact at baseline)×time interaction. This interaction was characterized by a steeper decline in the unimpaired than the impaired group at baseline.

      Conclusions

      Over an 18 year period, our results suggest that cognitive impairment in MS progresses, with declines being most evident on measures known to be most sensitive to MS-related cognitive difficulties both cross-sectionally and longitudinally.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Amato M.P.
        • Ponziani G.
        • Siracusa G.
        • Sorbi S.
        Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years.
        Arch Neurol. 2001; 58: 1602-1606
        • Amato M.P.
        • Portaccio E.
        • Goretti B.
        • Zipoli V.
        • Iudice A.
        • Della P.D.
        • et al.
        Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
        Mult Scler. 2010; 16: 1474-1482
        • Amato M.P.
        • Zipoli V.
        • Portaccio E.
        Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.
        J Neurol Sci. 2006; 245: 41-46
        • Amato M.P.
        • Zipoli V.
        • Portaccio E.
        Cognitive changes in multiple sclerosis.
        Expert Rev Neurother. 2008; 8: 1585-1596
        • Benton A.L.
        • Hamsher K.D.E.S.
        Multilingual aphasia examination manual of instructions. 2nd ed. AJA Associates, Iowa City1989
        • Benton A.L.
        • Sivan A.B.
        • Hamsher K.D.E.S.
        • Varney N.R.
        • Spreen O.
        Contributions to neuropsychological assessment: a clinical manual. Oxford University Press, New York1983
        • Bergendal G.
        • Fredrikson S.
        • Almkvist O.
        Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
        Eur Neurol. 2007; 57: 193-202
        • Bobholz J.A.
        • Rao S.M.
        Cognitive dysfunction in multiple sclerosis: a review of recent developments.
        Curr Opin Neurol. 2003; 16: 283-288
        • Chiaravalloti N.D.
        • Deluca J.
        Cognitive impairment in multiple sclerosis.
        Lancet Neurol. 2008; 7: 1139-1151
        • Delis D.C.
        • Kramer J.H.
        • Kaplan E.
        • Ober B.A.
        California verbal learning test manual. Western Psychological Services, Los Angeles1987
        • Denney D.R.
        • Lynch S.G.
        • Parmenter B.A.
        A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
        J Neurol Sci. 2008; 267: 129-136
        • Feinstein A.
        • Kartsounis L.D.
        • Miller D.H.
        • Youl B.D.
        • Ron M.A.
        Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study.
        J Neurol Neurosurg Psychiatry. 1992; 55: 869-876
        • Fischer J.S.
        • Priore R.L.
        • Jacobs L.D.
        • Cookfair D.L.
        • Rudick R.A.
        • Herndon R.M.
        • et al.
        Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.
        Ann Neurol. 2000; 48: 885-892
        • Fischer J.S.
        • Rudick R.A.
        • Cutter G.R.
        • Reingold S.C.
        The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.
        Mult Scler. 1999; 5: 244-250
        • Fisher E.
        • Lee J.C.
        • Nakamura K.
        • Rudick R.A.
        Gray matter atrophy in multiple sclerosis: a longitudinal study.
        Ann Neurol. 2008; 64: 255-265
        • Golden C.
        Stroop color and word test: a manual for clinical and experimental uses. Stoelting, Wood Dale1978
        • Goodlass H.
        • Kaplan E.
        Assessment of aphasia and related disorders. 2nd ed. Lea & Febiger, Philadelphia1983
        • Gronwall D.M.
        Paced auditory serial-addition task: a measure of recovery from concussion.
        Percept Mot Skills. 1977; 44: 367-373
        • Haase C.G.
        • Tinnefeld M.
        • Daum I.
        • Ganz R.E.
        • Haupts M.
        • Faustmann P.M.
        Cognitive, but not mood dysfunction develops in multiple sclerosis during 7 years of follow-up.
        Eur Neurol. 2004; 52: 92-95
        • Heaton R.K.
        Wisconsin card sorting test manual. Psychological Assessment Resources, Odessa1981
        • Hooper H.E.
        The Hooper visual organization test manual. Western Psychological Services, Los Angeles1958
        • Jacobs L.D.
        • Cookfair D.L.
        • Rudick R.A.
        • Herndon R.M.
        • Richert J.R.
        • Salazar A.M.
        • et al.
        A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG).
        Mult Scler. 1995; 1: 118-135
        • Kaplan E.F.
        • Goodglass H.
        • Weintraub S.
        Boston naming test. 2nd ed. Lea & Febiger, Philadelphia1983
        • Kujala P.
        • Portin R.
        • Ruutiainen J.
        The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up.
        Brain. 1997; 120: 289-297
        • Kurtzke J.F.
        Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
        Neurology. 1983; 33: 1444-1452
        • Morrow S.A.
        • Drake A.
        • Zivadinov R.
        • Munschauer F.
        • Weinstock-Guttman B.
        • Benedict R.H.
        Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline.
        Clin Neuropsychol. 2010; 24: 1131-1145
        • National Multiple Sclerosis Society
        A manual for the brief, repeatable battery of neuropsychological tests in MS. National MS Society, New York1990
        • Patti F.
        • Failla G.
        • Ciancio M.R.
        • L’Episcopo M.R.
        • Reggio A.
        Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study.
        Eur J Neurol. 1998; 5: 283-286
        • Piras M.R.
        • Magnano I.
        • Canu E.D.
        • Paulus K.S.
        • Satta W.M.
        • Soddu A.
        • et al.
        Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.
        J Neurol Neurosurg Psychiatry. 2003; 74: 878-885
        • Rao S.M.
        Neuropsychology of multiple sclerosis: a critical review.
        J Clin Exp Neuropsychol. 1986; 8: 503-542
        • Rao S.M.
        • Leo G.J.
        • Bernardin L.
        • Unverzagt F.
        Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.
        Neurology. 1991; 41: 685-691
        • Rao S.M.
        • Leo G.J.
        • Ellington L.
        • Nauertz T.
        • Bernardin L.
        • Unverzagt F.
        Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning.
        Neurology. 1991; 41: 692-696
        • Reuter F.
        • Zaaraoui W.
        • Crespy L.
        • Faivre A.
        • Rico A.
        • Malikova I.
        • et al.
        Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis.
        J Neurol Neurosurg Psychiatry. 2011; 82: 1157-1159
        • Ruff R.R.
        Ruff figural fluency test administration manual. Neuropsychological Resources, San Diego1988
        • Schwartz C.
        • Frohner R.
        Contribution of demographic, medical, and social support variables in predicting the mental health dimension of quality of life among people with multiple sclerosis.
        Health Soc Work. 2005; 30: 203-212
        • Schwid S.R.
        • Goodman A.D.
        • Weinstein A.
        • McDermott M.P.
        • Johnson K.P.
        Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial.
        J Neurol Sci. 2007; 255: 57-63
        • Smestad C.
        • Sandvik L.
        • Landro N.I.
        • Celius E.G.
        Cognitive impairment after three decades of multiple sclerosis.
        Eur J Neurol. 2010; 17: 499-505
        • Smith A.
        Symbol digit modalities test manual. Western Psychological Services, Los Angeles1973
        • Strober L.B.
        • Chiaravalloti N.
        • Moore N.
        • DeLuca J.
        Unemployment in multiple sclerosis (MS): the utility of the MS functional composite and cognitive testing.
        Mult Scler. 2014; 20: 112-115
        • Strober L.B.
        • Christodoulou C.
        • Benedict R.H.B.
        • Westervelt H.
        • Scherl W.
        • Weinstock-Guttman B.
        • et al.
        Unemployment in multiple sclerosis: the contribution of personality and disease.
        Mult Scler. 2012; 18: 644-650
        • Strober L.
        • Englert J.
        • Munschauer F.
        • Weinstock-Guttman B.
        • Rao S.
        • Benedict R.H.
        Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
        Mult Scler. 2009; 15: 1077-1084
        • Wechsler D.
        Manual for the Wechsler adult intelligence scale-revised. Psychological Corporation, New York1981
        • Wechsler D.
        Wechsler memory scale-revised manual. Psychological Corporation, San Antonio1987
        • Zakzanis K.K.
        Distinct neurocognitive profiles in multiple sclerosis subtypes.
        Arch Clin Neuropsychol. 2000; 15: 115-136